1 not yet recruiting, 1 recruiting. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
Follow TNBC: new trials by email Literature Review of TNBC trials Research Report on TNBC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer. Aipaluoli-tovorilimab plus AC-T chemotherapy as postoperative adjuvant therapy - TNBC, Adjuvant Therapy | Not applicable | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 59 | 2026-06-05 | 2026-06-03 |
| A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer treatment group - TNBC | Not applicable | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 43 | 2026-03-25 | 2026-03-24 |
The First Affiliated Hospital with Nanjing Medical University (1) · Tianjin Medical University Cancer Institute and Hospital (1)
China (1)